914 related articles for article (PubMed ID: 19345234)
1. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
Vlainić J; Pericić D
Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
[TBL] [Abstract][Full Text] [Related]
2. Zolpidem is a potent anticonvulsant in adult and aged mice.
Vlainić J; Pericić D
Brain Res; 2010 Jan; 1310():181-8. PubMed ID: 19914223
[TBL] [Abstract][Full Text] [Related]
3. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
[TBL] [Abstract][Full Text] [Related]
4. Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses.
Fahey JM; Grassi JM; Reddi JM; Greenblatt DJ
Pharmacol Biochem Behav; 2006 Jan; 83(1):21-7. PubMed ID: 16439007
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
Rundfeldt C; Wlaź P; Hönack D; Löscher W
J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice.
Hansen SL; Sperling BB; Sánchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):105-13. PubMed ID: 14687864
[TBL] [Abstract][Full Text] [Related]
8. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
[TBL] [Abstract][Full Text] [Related]
9. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. II. The novel imidazoquinazolines NNC 14-0185 and NNC 14-0189.
Löscher W; Rundfeldt C; Hönack D; Ebert U
J Pharmacol Exp Ther; 1996 Nov; 279(2):573-81. PubMed ID: 8930159
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of the hypnotic zolpidem in vivo.
Crestani F; Martin JR; Möhler H; Rudolph U
Br J Pharmacol; 2000 Dec; 131(7):1251-4. PubMed ID: 11090095
[TBL] [Abstract][Full Text] [Related]
11. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
Perrault G; Morel E; Sanger DJ; Zivkovic B
J Pharmacol Exp Ther; 1992 Oct; 263(1):298-303. PubMed ID: 1403792
[TBL] [Abstract][Full Text] [Related]
12. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
13. Sedative and anticonvulsant effects of zolpidem in adult and aged mice.
Pericić D; Vlainić J; Strac DS
J Neural Transm (Vienna); 2008 Jun; 115(6):795-802. PubMed ID: 18217189
[TBL] [Abstract][Full Text] [Related]
14. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
Löscher W; Rundfeldt C; Hönack D; Ebert U
J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
[TBL] [Abstract][Full Text] [Related]
15. Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage.
Kadriu B; Guidotti A; Costa E; Auta J
Toxicology; 2009 Feb; 256(3):164-74. PubMed ID: 19111886
[TBL] [Abstract][Full Text] [Related]
16. Neuropharmacological screening of two 1,5-benzodiazepine compounds in mice.
Ben-Cherif W; Gharbi R; Sebai H; Dridi D; Boughattas NA; Ben-Attia M
C R Biol; 2010 Mar; 333(3):214-9. PubMed ID: 20338539
[TBL] [Abstract][Full Text] [Related]
17. Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem.
Auta J; Impagnatiello F; Kadriu B; Guidotti A; Costa E
Neuropharmacology; 2008 Aug; 55(2):148-53. PubMed ID: 18555494
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
[TBL] [Abstract][Full Text] [Related]
19. Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism.
Tchekalarova J; Georgiev V
Neuropeptides; 2006 Oct; 40(5):339-48. PubMed ID: 17045647
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute versus chronic theophylline administration on acute restraint stress-induced increase of pentylenetetrazol seizure threshold in mice.
Tchekalarova J; Georgiev V
Brain Res Bull; 2006 Feb; 68(6):464-8. PubMed ID: 16459204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
